Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A 3-year randomized

Søren Helbo Skaarup1, Johannes Martin Schmid1, Tina Skjold1

  • 1Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.

Summary

Intralymphatic allergen immunotherapy (ILIT) significantly reduced grass pollen allergy symptoms and medication use in the first season. A booster injection did not provide additional benefits in this 3-year study.